Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
138.37
-0.34 (-0.25%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Agilent Technologies Revenue
Agilent Technologies had revenue of $1.84B in the quarter ending April 30, 2026, with 10.01% growth. This brings the company's revenue in the last twelve months to $7.23B, up 9.11% year-over-year. In the fiscal year ending October 31, 2025, Agilent Technologies had annual revenue of $6.95B with 6.73% growth.
Revenue (ttm)
$7.23B
Revenue Growth
+9.11%
P/S Ratio
5.40
Revenue / Employee
$399,558
Employees
18,100
Market Cap
39.08B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 6.95B | 438.00M | 6.73% |
| Oct 31, 2024 | 6.51B | -323.00M | -4.73% |
| Oct 31, 2023 | 6.83B | -15.00M | -0.22% |
| Oct 31, 2022 | 6.85B | 529.00M | 8.37% |
| Oct 31, 2021 | 6.32B | 980.00M | 18.36% |
| Oct 31, 2020 | 5.34B | 176.00M | 3.41% |
| Oct 31, 2019 | 5.16B | 249.00M | 5.07% |
| Oct 31, 2018 | 4.91B | 442.00M | 9.88% |
| Oct 31, 2017 | 4.47B | 270.00M | 6.43% |
| Oct 31, 2016 | 4.20B | 164.00M | 4.06% |
| Oct 31, 2015 | 4.04B | -10.00M | -0.25% |
| Oct 31, 2014 | 4.05B | 154.00M | 3.95% |
| Oct 31, 2013 | 3.89B | -2.96B | -43.22% |
| Oct 31, 2012 | 6.86B | 243.00M | 3.67% |
| Oct 31, 2011 | 6.62B | 1.17B | 21.51% |
| Oct 31, 2010 | 5.44B | 963.00M | 21.49% |
| Oct 31, 2009 | 4.48B | -1.29B | -22.39% |
| Oct 31, 2008 | 5.77B | 354.00M | 6.53% |
| Oct 31, 2007 | 5.42B | 447.00M | 8.99% |
| Oct 31, 2006 | 4.97B | 288.00M | 6.15% |
| Oct 31, 2005 | 4.69B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 16.98B |
| Labcorp Holdings | 14.35B |
| Quest Diagnostics | 11.56B |
| ICON Public Limited Company | 8.29B |
| Illumina | 4.49B |
| IDEXX Laboratories | 4.45B |
| Mettler-Toledo International | 4.13B |
| Waters | 3.77B |
A News
- 4 days ago - Agilent Research Catalyst Award Presented to Eastern Institute of Technology, Ningbo - Business Wire
- 5 days ago - Agilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26 - Business Wire
- 10 days ago - Agilent receives EU approval for PD-L1 IHC 22C3 pharmDx - TheFly
- 10 days ago - Agilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma - Business Wire
- 14 days ago - Agilent Increases Its Investment in HALO X-ray Technologies - Business Wire
- 19 days ago - Agilent receives FDA approval for PD-L1 IHC 28-8 pharmDx assay - TheFly
- 19 days ago - Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma - Business Wire
- 24 days ago - Agilent price target raised to $135 from $130 at Jefferies - TheFly